MAP2K7 and hepatocellular carcinoma: Li et al. [39] reported that hepatic stellate cell‐derived COMP drives HCC progression by activating mitogen‐activated protein kinase kinase 7 (MEK)/mitogen‐activated protein kinase (ERK) and PI3K/AKT signaling pathways.